Table 2.

Mouse studies on the role of tumor-derived TF+ MVs in cancer-associated thrombosis

Tumor typeMouseTumor siteConclusionReference
Human colorectal cancer cell lines SCID Subcutaneous Human TF antigen in plasma 83 
Human pancreatic cancer cell line L3.6pl Nude Orthotopic Human TF MV activity and TAT in plasma 84 
Mouse pancreatic cancer cell line Panc02 and lung cancer cell line LLC1 C57BL/6J Subcutaneous Increased thrombosis in mesenteric ferric chloride model 57 
Human pancreatic cancer cell lines HPAF-II and HPAC Nude Subcutaneous and orthotopic Human TF antigen and MV activity and TAT in plasma 67 
Mouse pancreatic cancer cell line Panc02 C57BL/6J Subcutaneous Increased thrombosis in IVC stenosis model 85 
Human pancreatic cancer cell lines BxPc-3 and L3.6pl Nude Orthotopic Increased thrombosis in IVC stenosis model 54 
Human pancreatic cancer cell line BxPc-3 Nude Orthotopic Human TF+ MVs increase thrombosis in IVC stasis model 30 
Tumor typeMouseTumor siteConclusionReference
Human colorectal cancer cell lines SCID Subcutaneous Human TF antigen in plasma 83 
Human pancreatic cancer cell line L3.6pl Nude Orthotopic Human TF MV activity and TAT in plasma 84 
Mouse pancreatic cancer cell line Panc02 and lung cancer cell line LLC1 C57BL/6J Subcutaneous Increased thrombosis in mesenteric ferric chloride model 57 
Human pancreatic cancer cell lines HPAF-II and HPAC Nude Subcutaneous and orthotopic Human TF antigen and MV activity and TAT in plasma 67 
Mouse pancreatic cancer cell line Panc02 C57BL/6J Subcutaneous Increased thrombosis in IVC stenosis model 85 
Human pancreatic cancer cell lines BxPc-3 and L3.6pl Nude Orthotopic Increased thrombosis in IVC stenosis model 54 
Human pancreatic cancer cell line BxPc-3 Nude Orthotopic Human TF+ MVs increase thrombosis in IVC stasis model 30 

TAT, thrombin-antithrombin [complex].

or Create an Account

Close Modal
Close Modal